Polymyositis is a rare inflammatory illness that causes inflammation and increasing weakening in the skeletal muscles, especially those closest to the body’s trunk (proximal muscles). Since the precise etiology of the condition is unknown, it is categorized as an idiopathic inflammatory myopathy, in which the immune system mistakenly targets healthy muscle tissue. Controlling inflammation, reducing symptoms, averting consequences, and enhancing quality of life are the goals of polymyositis treatment.